Immunovant IMVT Q1 2026 Earnings EPS Miss Driven by Higher RD Investment Stock Holds Steady UROY Q1 2026 Earnings Strong EPS Beat as Uranium Royalty Income Surprises RPT Q1 2026 Earnings Significant EPS Miss Amid Challenging Real Estate Market UA Q1 2026 Earnings EPS Misses Estimates as Turnaround Efforts Continue MCRB Q1 2026 Earnings EPS Misses Estimates Amid Continued Clinical Progress BBD Q1 2026 Earnings EPS Miss Weighs on Shares as Profitability Pressures Emerge